Effect of oral administration of icariin on periodontitis associated alveolar bone resorption in an osteoporosis mouse model

doi:10.19439/j.sjos.2019.01.006

Abstract

Abstract: PURPOSE: To study the effect of oral administration of icariin (ICA) on periodontitis associated alveolar bone resorption in an osteoporosis mouse model. METHODS: Three-month old, female C57BL/6J mice were randomly divided into 3 groups: normal group (SHAM), ovariectomy + oral smearing of Porphyromonas gingivalis (Pg) + icariin group (OVX+Pg+ICA), ovariectomy+ Pg group (OVX+Pg). On the second week, the mice underwent ovariectomy to induce osteoporosis. On the fourth week, the mice were treated with Pg by oral smearing for 1 week, 1 time/day. The samples were harvested on the 12th week: the left mandibles were harvested to make the sections and histological staining, to analyze the differences of bone resorption areas among the three groups; the right mandibles were harvested for methylene blue staining, to analyze the differences of bone resorption depth among the three groups. Protein from the periodontal tissues were extracted to analyze the differences of osteoblastic related protein expression level among the three groups. SPSS 16.0 software package was used for statistical analysis. RESULTS: Histological analysis of murine femurs and periodontal tissues demonstrated that the model of periodontitis in osteoporosis mice was successfully created in this study. Quantification of the histological staining showed that compared with OVX+Pg group, icariin treatment decreased the depth of CEJ-ABC and the areas of alveolar bone resorption(P<0.05); Western blot results showed icariin treatment could significantly increase the protein expression level of Runx2, OSX, OCN and OPN in periodontal tissues(P<0.05). CONCLUSIONS: Icariin treatment can effectively prevent both bone loss in osteoporosis and alveolar bone resorption induced by periodontitis.

Key words: Icariin, Osteoporosis, Periodontitis, Alveolar bone absorption

CLC Number:

R782.1

YANG Wei, ZHAO Pin, TAO Mei-ling, LUO Yuan. Effect of oral administration of icariin on periodontitis associated alveolar bone resorption in an osteoporosis mouse model[J]. Shanghai Journal of Stomatology, 2019, 28(1): 30-35.

References

[1] Gunn CA, Weber JL, Kruger MC.Diet, weight, cytokines and bone health in postmenopausal women[J]. J Nutr Health Aging, 2014, 18(5): 479-486.
[2] Wright NC, Looker AC, Saag KG, et al.The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine[J]. J Bone Miner Res, 2014, 29(11): 2520-2526.
[3] Kinane DF, Stathopoulou PG, Papapanou PN.Periodontal diseases[J]. Nat Rev Dis Primers, 2017, 3: 17038.
[4] Rocha M, Nava LE, Vazquez de la Torre C, et al. Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: a randomized, placebo-controlled trial[J]. J Periodontol, 2001, 72(2): 204-209.
[5] Jeffcoat MK.Safety of oral bisphosphonates: controlled studies on alveolar bone[J]. Int J Oral Maxillofac Implants, 2006, 21(3): 349-353.
[6] Chen KM, Ma HP, Ge BF, et al.Icariin enhances the osteogenic differentiation of bone marrow stromal cells but has no effects on the differentiation of newborn calvarial osteoblasts of rats[J]. Pharmazie, 2007, 62(10): 785-789.
[7] An J, Yang H, Zhang Q, et al.Natural products for treatment of osteoporosis: The effects and mechanisms on promoting osteoblast-mediated bone formation[J]. Life Sci, 2016, 147: 46-58.
[8] Recker R, Lappe J, Davies KM, et al.Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients[J]. J Bone Miner Res, 2004, 19(10):1628-1633.
[9] Xu XC, Chen H, Zhang X, et al.Effects of oestrogen deficiency on the alveolar bone of rats with experimental periodontitis[J]. Mol Med Rep, 2015, 12(3): 3494-3502.
[10] Ku SK, Cho HR, Sung YS, et al.Effects of calcium gluconate on experimental periodontitis and alveolar bone loss in rats[J]. Basic Clin Pharmacol Toxicol, 2011, 108(4): 241-250.
[11] Lin TH, Lung CC.Association between periodontal disease and osteoporosis by gender: a nationwide population-based cohort study[J]. Medicine (Baltimore), 2015, 94(7): e553.
[12] Tezal M, Wactawski-Wende J, Grossi SG, et al.The relationship between bone mineral density and periodontitis in postmenopausal women[J]. J Periodontol, 2000, 71(9): 1492-1498.
[13] Hsieh TP, Sheu SY, Sun JS, et al.Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-kappaB regulated HIF-1alpha and PGE(2) synthesis[J]. Phytomedicine, 2011, 18(2-3): 176-185.
[14] Liu T, Zhang X, Luo Y, et al.Slowly delivered icariin/allogeneic bone marrow-derived mesenchymal stem cells to promote the healing of calvarial critical-size bone defects[J]. Stem Cells Int, 2016, 2016: 1416047.
[15] Liu M, Zhong C, He RX, et al.Icariin associated with exercise therapy is an effective treatment for postmenopausal osteoporosis[J]. Chin Med J (Engl), 2012, 125(10): 1784-1789.
[16] Liu H, Xiong Y, Zhu X, et al.Icariin improves osteoporosis, inhibits the expression of PPARgamma, C/EBPalpha, FABP4 mRNA, N1ICD and jagged1 proteins, and increases Notch2 mRNA in ovariectomized rats[J]. Exp Ther Med, 2017, 13(4): 1360-1368.
[17] Liu Y, Zuo H, Liu X, et al.The antiosteoporosis effect of icariin in ovariectomized rats: a systematic review and meta-analysis[J]. Cell Mol Biol (Noisy-le-grand), 2017, 63(11): 124-131.
[18] Komori T.Animal models for osteoporosis[J]. Eur J Pharmacol, 2015, 759: 287-294.
[19] Zhang S, Feng P, Mo G, et al.Icariin influences adipogenic differentiation of stem cells affected by osteoblast-osteoclast co-culture and clinical research adipogenic[J]. Biomed Pharmacother, 2017, 88:436-442.
[20] Komori T.Roles of Runx2 in skeletal development[J]. Adv Exp Med Biol, 2017, 962:83-93.
[21] Sui BD, Hu CH, Zheng CX, et al.Microenvironmental views on mesenchymal stem cell differentiation in aging[J]. J Dent Res, 2016, 95(12):1333-1340.